A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Decamethonium
Remimazolam
The risk or severity of sedation can be increased when Serotonin is combined with Remimazolam.
Decamethonium
Lasmiditan
The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Lasmiditan.
Decamethonium
Esketamine
The risk or severity of adverse effects can be increased when Serotonin is combined with Esketamine.
Decamethonium
Gilteritinib
The therapeutic efficacy of Serotonin can be decreased when used in combination with Gilteritinib.
Decamethonium
Valproate bismuth
The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Valproate bismuth.
Decamethonium
Gepefrine
The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Gepefrine.
Decamethonium
Methoxyphenamine
The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Methoxyphenamine.
Decamethonium
Nicomorphine
The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Nicomorphine.
Decamethonium
Mephedrone
The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Mephedrone.
Decamethonium
Ritobegron
The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Ritobegron.
Decamethonium
Iofetamine I-123
The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Iofetamine I-123.
Decamethonium
Eluxadoline
The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Eluxadoline.
Decamethonium
Methylthioninium
The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Serotonin.
Decamethonium
Chlorphentermine
The risk or severity of serotonin syndrome can be increased when Chlorphentermine is combined with Serotonin.
Decamethonium
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of serotonin syndrome can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Serotonin.
Decamethonium
Bezitramide
The risk or severity of serotonin syndrome can be increased when Bezitramide is combined with Serotonin.
Decamethonium
Mephentermine
The risk or severity of serotonin syndrome can be increased when Mephentermine is combined with Serotonin.
Decamethonium
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Serotonin.
Decamethonium
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Serotonin.
Decamethonium
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Serotonin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3